Akin Advises Pharmakon Advisors in its $400 Million Debt Financing for Novocure

May 7, 2024

Reading Time : 1 min

Contact:

Jacinta O'Shea-Ramdeholl

Director of Communications

Scott Wasserman

Senior Media Relations Manager

(New York) – Akin advised Pharmakon Advisors LP in its new five-year up to $400 million committed senior secured credit facility for Novocure. The committed capital will be available for Novocure in four tranches of $100 million.

The Akin team was led by tax partner Geoffrey Secol and included tax partner David Snyder; health care & life sciences partner Nate Brown; and international trade partner Nnedinma Ifudu Nweke; senior counsel Jo-Ellyn Klein; counsel Sudhana Bajracharya and Ekaterina Lyashenko; and associates Cameron Jones, Joseph Lordi, Jenna Becker, Caroline Kessler and Angela Sbano.

Additional details on the transaction can be found here.

Akin is a leading international law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.

# # #

Share This Insight

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.